Interesting IREN Put And Call Options For February 2026

IREN Ltd (current price $41.47) presents two option strategies: selling a $40 put at a $3.75 bid would obligate purchase at $40 with a net cost basis of $36.25 and is quoted as ~4% OTM with a 63% chance to expire worthless, implying a 9.38% return (77.77% annualized). Alternatively, selling a $44 covered call at a $4.20 bid from a $41.47 entry yields a 16.23% total return if called to Feb 2026, the $44 strike is ~6% OTM with a 48% chance to expire worthless and a reported 10.13% extra return (84.01% annualized). Implied volatilities are elevated (put 107%, call 99%) versus trailing 12‑month volatility of 98%, highlighting option-rich premiums but material upside risk if shares rally.

Analysis

Market structure: The current IREN option setup favors yield-seeking retail/CTA sellers and market makers who collect high premia (puts IV 107%, calls 99% vs realized ~98%). Sellers of cash‑secured puts ($40 strike premium $3.75 → net entry $36.25) benefit if assigned; covered‑call sellers capture ~16.2% to Feb‑2026 but cap upside. High IV and a ~63% OTM‑put survival probability signal elevated demand for downside protection and/or low float idiosyncratic risk, not broad systemic stress.

Risk assessment: Tail risk is a >20% adverse gap (corporate event, regulatory hit, or liquidity squeeze) that would force assignment and immediate mark‑to‑market losses; broker margin/assignment latency and borrow constraints are second‑order risks. In the next days to weeks, theta decay and IV movement dominate P/L; over quarters, company fundamentals (cash flow, regulatory news) determine whether selling premium was prudent. Key hidden dependencies: option liquidity (wide spreads), dividend timing, and concentrated holder actions.

Trade implications: Direct plays: cash‑secured put sale at $40 (target effective buy $36.25) sized to 1–3% portfolio for tactical accumulation; if owning shares, sell $44 covered calls to harvest the $4.20 premium but cap upside at ~16.2% to Feb‑2026. If unwilling to take assignment, prefer defined‑risk put credit spreads (e.g., $40/$36) to limit max loss; avoid naked short volatility beyond 2–3% position size given IV ~100%.

Contrarian angle: Consensus focuses on YieldBoost but underweights skew — puts are pricier than calls, implying asymmetric downside fear; market may be underpricing assignment/illiquidity costs and overpricing annualized return (77–84%) vs real drawdown risk. Historical parallels: names with >100% IV typically mean‑revert post‑event; if IV compresses 20–40%, short‑premium trades become lucrative but require strict sizing and stop rules.

Key Decisions for Investors

• Establish a cash‑secured short put position on IREN: sell 1–3% portfolio notional of the $40 Feb‑2026 put (collect $3.75, target net entry $36.25). Size so maximum assignment equals 3% equity; immediately buy downside protection (long $32–$34 puts) if position exceeds 2% of portfolio.
• If already long IREN near $41.47, sell the $44 Feb‑2026 covered call (collect $4.20) on 1–3% position to lock a 16.2% capped return; set rule to roll up/extend if stock >$48 or buy back calls when remaining premium >50% of initial to avoid assignment into gap risk.
• Prefer a defined‑risk alternative: sell a $40/$36 put credit spread sized to 1–3% portfolio to receive premium while capping max loss at $4.00/share. Close if spread mark‑to‑market widens >50% or IV jumps >25 percentage points.
• Trigger/monitor rules (actionable): watch IREN IV term structure and bid/ask spreads daily; if front‑month IV falls >20% or put bid tightens by >30%, scale into additional short‑premium (up to total 3%); if stock trades below $32 or a corporate/regulatory event is announced, exit/hedge within 24 hours.